A less common case of anti-MDA5 and anti-Ro52 antibody-positive juvenile dermatomyositis complicated with macrophage activation syndrome

被引：0
|
作者：
Zhang, Li [1 ]
Zhang, Haiqing [2 ]
Liu, Shanshan [2 ]
Zhang, Ning [2 ]
Wang, Yun [2 ,3 ]
机构：
[1] Qingdao Univ, Sch Basic Med, Dept Immunol, Qingdao, Peoples R China
[2] Qingdao Women & Childrens Hosp, Clin Lab, Qingdao, Peoples R China
[3] Qingdao Women & Childrens Hosp, Clin Lab, Qingdao 266034, Shandong, Peoples R China
来源：
CLINICAL CASE REPORTS | 2024年 / 12卷 / 03期
关键词：
anti-MDA5; antibody; anti-Ro52; interstitial lung disease; juvenile dermatomyositis; macrophage activation syndrome;
D O I：
10.1002/ccr3.8613
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [41] Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review
    Tsz-Wing Yeung
    Kai-Ning Cheong
    Yu-Lung Lau
    Kei-Chiu Niko Tse
    Pediatric Rheumatology, 19
  • [42] Aggressive multi-combination therapy for anti-MDA5 antibody-positive dermatomyositis-rapidly progressive interstitial lung disease
    Hata, Kenichiro
    Kotani, Takuya
    Matsuda, Shogo
    Fujiki, Youhei
    Suzuka, Takayasu
    Kiboshi, Takao
    Wada, Yumiko
    Shiba, Hideyuki
    Shoda, Takeshi
    Kagitani, Maki
    Takeuchi, Tohru
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)
  • [43] Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report
    Quintana-Ortega, Cristian
    Remesal, Agustin
    Ruiz de Valbuena, Marta
    de la Serna, Olga
    Laplaza-Gonzalez, Maria
    Alvarez-Rojas, Elena
    Udaondo, Clara
    Alcobendas, Rosa
    Murias, Sara
    MODERN RHEUMATOLOGY CASE REPORTS, 2021, 5 (01) : 101 - 107
  • [44] Successful peficitinib addition on anti-MDA5 antibody-positive dermatomyositis refractory to triple therapy and glucocorticoid reduction
    Oba, Yuki
    Yamanouchi, Masayuki
    Ikuma, Daisuke
    Mizuno, Hiroki
    Inoue, Noriko
    Sekine, Akinari
    Hasegawa, Eiko
    Suwabe, Tatsuya
    Sawa, Naoki
    Ubara, Yoshifumi
    SAGE OPEN MEDICAL CASE REPORTS, 2022, 10
  • [45] Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease
    Witkowska, Anna Barbara
    Cowley, Sharon
    Dempsey, Philip
    Stack, John
    BMJ CASE REPORTS, 2022, 15 (03)
  • [46] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases
    Mehta, Asmita A.
    Paul, Tisa
    Cb, Mithun
    Haridas, Nithya
    BMJ CASE REPORTS, 2021, 14 (04)
  • [47] Serum uric acid, a potential biomarker for interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis
    Xie, Huaiya
    Fan, Junping
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
  • [48] Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review
    Yeung, Tsz-Wing
    Cheong, Kai-Ning
    Lau, Yu-Lung
    Tse, Kei-Chiu Niko
    PEDIATRIC RHEUMATOLOGY, 2021, 19 (01)
  • [49] Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis
    Yoshinao Muro
    Kazumitsu Sugiura
    Masashi Akiyama
    Clinical Rheumatology, 2013, 32 : 395 - 398
  • [50] Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer
    Toshifumi Yamaoka
    Chie Doi
    Akinori Yokomi
    Atsushi Tanemura
    Hiroyuki Murota
    Mamori Tani
    Hiroko Saruban
    Yasuhito Hamaguchi
    Manabu Fujimoto
    Ichiro Katayama
    European Journal of Dermatology, 2014, 24 : 490 - 491
12345